Therapeutic potential of targeting SHP2 in human developmental disorders and cancers
Dadong Shen(Zhejiang University of Technology), Haopeng Sun(China Pharmaceutical University), Meiyang Xi(Shaoxing University), Jinlin Zhu(Zhejiang Medicine (China)), Guofeng Wu(Zhejiang Medicine (China)), Wenxia Chen(Zhejiang Medicine (China)), Runpu Shen(Shaoxing University)
Cited by 72
Related Papers
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196